Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer.

Anastassia LöserBurkhard BeyerCedric Oliver CarlBenjamin LöserYamini NagarajThorsten FrenzelCordula PetersenAndreas KrüllMarkus GraefenRudolf Schwarz

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)

HDR-BT/EBRT is a well-tolerated treatment option for elderly men ≥75 years with a limited number of comorbidities and localized intermediate- or high-risk prostate cancer. IMRT should be favored since side effects were significantly reduced in IMRT-treated patients.

Keyphrases

prostate cancer
high dose
radiation therapy
risk factors
radical prostatectomy
middle aged
end stage renal disease
newly diagnosed
ejection fraction
low dose
stem cell transplantation
oxidative stress
peritoneal dialysis
prognostic factors
locally advanced
squamous cell carcinoma
radiation induced
rectal cancer